BioCryst Pharmaceuticals (BCRX) in Focus: Stock Jumps 6.2%
BioCryst Pharmaceuticals, Inc. BCRX was a big mover last session, as the company saw its shares rise over 6% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This reverses the recent trend for the company as the stock is now down 75.7% in the past one-month time frame.
None of the estimates for this stock were revised over the past 30 days. The Zacks Consensus Estimate also remained unchanged over the same time frame. Yesterday’s price action is encouraging though, so make sure to keep a close watch on this firm in the near future.
BioCryst Pharmaceuticals currently carries a Zacks Rank #4 (Sell), while its Earnings ESP is 0.00%.
A better-ranked stock in the same industry is Aratana Therapeutics, Inc. PETX, sporting a Zacks Rank #1 (Strong Buy).
Is BCRX going up? Or down? Predict to see what others think: Up or Down
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
BIOCRYST PHARMA (BCRX): Free Stock Analysis Report
ARATANA THERAP (PETX): Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
